Primordial Germ Cell Differentiation Through PSC Tight-Junction Bypass

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating primordial germ cells (PGCs) from pluripotent stem cells (PSCs) require genetic modifications and chemical treatments to revert primed PSCs to a more naïve state, which is inefficient and costly, and do not effectively utilize the BMP-SMAD1 pathway for PGC differentiation.

Innovation Solution

Inhibit or bypass tight junction formation in PSCs by methods such as CRISPR interference or basolateral stimulation with BMP, allowing BMP to contact the cells directly, thereby facilitating PGC differentiation without genetic modification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If genetic modifications and chemical treatments are used to revert primed PSCs to a naïve state, then PGC differentiation can be achieved, but the process becomes inefficient and costly

Engineering Contradiction:
ImprovePGC differentiation efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes the unnecessary genetic modification step from the PGC differentiation process. By demonstrating that primed PSCs can directly differentiate into PGCs through BMP4 treatment alone, the invention eliminates the complex reversion to naïve state step, thereby reducing process complexity while maintaining differentiation efficiency

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent inverts the conventional understanding of PSC differentiation by showing that primed PSCs (not naïve PSCs) are the appropriate starting point for PGC differentiation. This inversion simplifies the process by working with the naturally committed state of cultured PSCs rather than attempting to revert them

Inventive Principle:
Principle #13The other way round (Inversion)

2Strength

If tight junction formation is allowed in PSCs, then cells maintain structural integrity, but BMP cannot contact cells directly for differentiation

Engineering Contradiction:
Improvecell structural integrityVSAvoidBMP accessibility
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The patent uses an intermediary approach by treating PSCs with BMP4, which acts as a signaling molecule that can penetrate or interact with the tight junction structure. The BMP4 treatment mediates the transmission of differentiation signals to the cells without requiring complete disruption of their structural integrity

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the functional state of tight junctions through BMP4 signaling, transforming them from a barrier that prevents BMP access into a permeable structure that allows differentiation signals to pass through while maintaining basic cellular integrity

Inventive Principle:
Principle #35Parameter changes

3Productivity

If conventional IVF methods are used, then fertilization can occur, but problems such as low oocyte retrieval and ovarian hyperstimulation syndrome occur

Engineering Contradiction:
Improveoocyte retrieval efficiencyVSAvoidovarian hyperstimulation syndrome
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by generating PGCs from PSCs in advance before fertilization is needed. This allows for pre-differentiation and quality control of germ cells, eliminating the need for hormone stimulation and surgical retrieval of mature oocytes, thereby preventing ovarian hyperstimulation syndrome while ensuring adequate cell supply

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent skips the natural developmental stages that cause harm in conventional IVF. By directly differentiating PSCs into PGCs and then into mature gametes in vitro, the method bypasses the hormone stimulation and surgical retrieval steps that cause ovarian hyperstimulation syndrome, achieving fertilization capability without the harmful intermediate steps

Inventive Principle:
Principle #21Skipping (Rushing through)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves efficient and cost-effective generation of PGCs with minimal invasive procedures, addressing issues like low oocyte retrieval and ovarian hyperstimulation syndrome, and enabling trans-differentiation for fertility treatments.

Implementation Method 1

do not effectively utilize the BMP-SMAD1 pathway for PGC differentiation

Methodology Applied
Scientific EffectBMP-SMAD1 signaling pathway:

Data Source

PatentUS20250263654A1Primordial germ cells
Publication Date: 2025.08.21 THE J DAVID GLADSTONE INSTITUTES
  • US20250263654A1 patent drawing
  • US20250263654A1 patent drawing
  • US20250263654A1 patent drawing

AI summary

Described herein are compositions, systems, and methods for obtaining primordial germ cells (PGCs) from pluripotent stem cells (PSCs). Inhibiting or bypassing tight junction formation in a population of pluripotent stem cells to generate a modified cell population, and contacting the modified cell population with BMP. Where inhibiting or bypassing tight junction formation includes incubating the population of pluripotent stem cells.